GleanMark

ONCOSIGNATURE Trademark

ONCOSIGNATURE is a USPTO trademark filed by Acrivon Therapeutics, Inc.. Status: Pending.

Trademark Facts

MarkONCOSIGNATURE
Serial Number98115652
StatusPending
Filing Date2023-08-03
Mark TypeWord
Nice Classes005 (Pharmaceuticals), 044 (Medical Services)
OwnerAcrivon Therapeutics, Inc.
Attorney of RecordSARA M. BAUER
Prosecution Events20
Latest EventNOAM on 2026-03-31

Goods & Services

Pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy predication and analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits or does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes; Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, consultancy and advisory services; individual medical counseling services provided to patients; providing a website featuring information in the fields of oncology and precision medicine; providing medical information to medical professionals in the form of reports in the fields of oncology and precision medicine

Related